The probiotics sector is forecast to soar by 23% in China to 2020 and even greater long-term growth beckons if the industry unites to better educate consumers and regulators.
There is considerable promise in manipulating the gut microbiome to treat the two main forms of inflammatory bowel disease (IBD), ulcerative colitis and Crohn’s disease, according to a new review.
Microbiome app developer DayTwo has secured €12 million (€10.6m) investment from Seventure Partners’ Health for Life Capital fund, as part of a series A round of fundraising.
A higher ratio of omega-3 to omega-6 enzymes is linked to better survival rate in bowel cancer according to a recent study published in the British Journal of Cancer.
Lonza expects to complete its $5.5bn (€5.2bn) takeover of Capsugel SA in the next few days having secured approval from competition authorities around the world.
Four-week supplementation with vitamin K2 MK-7 (menaquinone-7) significantly improves vascular calcification (VC), according to a new study published in BMC Nephrology.
Probiotic giant Ganeden says its new immune ingredient looks to take the benefits of its validated strain into categories and areas that probiotics cannot be used.
The industry can do more to target fashionable high protein foods and drinks to the over 65s market, while rest of Europe should follow Norway with nutrition-filled NPD for the elderly, say researchers.
Sham operators are undermining the field of nutrigenomics and personalised nutrition, according to the author new research that shines light on how dietary changes thousands of years ago impacted the human genome.
Supplementing open-heart surgery patients with omega-3 polyunsaturated fatty acids could reduce time spent in hospital and lower risk of complications.
